[1] |
LEGARTH C,GRIMM D,WEHLAND M,et al.The impact of vitamin D in the treatment of essential hypertension[J]. Int J Mol Sci,2018,19(2):455.
|
[2] |
LIU W,ZHANG L,XU H J,et al.The anti-inflammatory effects of vitamin D in tumorigenesis[J]. Int J Mol Sci,2018,19(9):2736.
|
[3] |
李建婷,张海清,李明龙. 桥本甲状腺炎免疫相关机制的研究进展[J]. 细胞与分子免疫学杂志,2014,30(7):771-773.
|
[4] |
尚敬,于璐,李全忠,等. 桥本甲状腺炎甲状腺功能减退患者血清1,25-二羟维生素D3及白细胞介素-8水平变化及意义[J]. 中华实用诊断与治疗杂志,2018,32(6):575-577.
|
[5] |
胡映玉. 维生素D缺乏与甲状腺疾病相关性的研究综述[J]. 中国卫生标准管理,2019,10(15):60-62.
|
[6] |
中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南——甲状腺炎[J]. 中华内科杂志,2008,47(9):784-785.
|
[7] |
HOLICK M F,BINKLEY N C,BISCHOFF-FERRARI H A,et al. Evaluation,treatment,and prevention of vitamin D deficiency:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2011,96(7):1911-1930.
|
[8] |
SHOENFELD N,AMITAL H,SHOENFELD Y.The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease[J]. Nat Clin Pract Rheumatol,2009,5(2):99-105.
|
[9] |
傅莉萍,金剑虹,王保法,等. 骨化三醇对桥本甲状腺炎患者TPOAb、TgAb、Th17/Treg相关细胞因子的影响[J]. 浙江医学,2019,41(22):2398-2401.
|
[10] |
UCAN B,SAHIN M,SAYKI ARSLAN M,et al.Vitamin D treatment in patients with Hashimoto's thyroiditis may decrease the development of hypothyroidism[J]. Int J Vitam Nutr Res,2016,86(1-2):9-17.
|
[11] |
姜文佳. 骨关节炎患者血清1,25(OH)_2D_3、IL-17和IL-10水平的变化及临床意义[J]. 检验医学,2019,34(3):202-205.
|
[12] |
KIVITY S,AGMON-LEVIN N,ZISAPPL M,et al.Vitamin D and autoimmune thyroid diseases[J]. Cell Mol Immunol,2011,8(3):243-247.
|
[13] |
CHAILURKIT LO,AEKPLAKORN W,ONGPHIPHADHANALUL B.High vitamin D status in younger individuals is associated with low circulating thyrotropin[J]. Thyroid,2013,23(1):25-30.
|
[14] |
柳迎昭,朱晨露,田洁,等. 桥本甲状腺炎患者 Th17细胞比例升高[J]. 中华内分泌代谢杂志,2012,28(8):638-640.
|
[15] |
吴汉妮,余玲,屈新才,等. IL-23、IL-17在桥本氏甲状腺炎患者甲状腺组织中的表达[J]. 细胞与分子免疫学杂志,2008,24(12):1182-1184.
|
[16] |
吴田田,童亚林,姚咏明. 白介素-35在炎症及自身免疫性疾病中的免疫学效应及临床意义[J]. 中华重症医学电子杂志(网络版),2018,4(4):314-319.
|